Protein homeostasis as a therapeutic target for diseases of protein conformation

Barbara Calamini1, Richard I Morimoto

  • 1Department of Neurobiology and Center for Drug Discovery, Duke University, Durham, NC, USA.

Insights

Targeting protein homeostasis (proteostasis) by enhancing cellular stress responses and molecular chaperone activity offers a promising therapeutic strategy. This approach aims to protect against protein misfolding and aggregation in various diseases.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Pharmacology

Background:

  • Protein misfolding and aggregation are linked to numerous human diseases, creating a need for novel therapeutic targets.
  • The proteostasis network (PN) maintains proteome stability through stress signaling, molecular chaperones, and clearance systems.
  • Aging, stress, and disease can impair PN function, leading to protein conformational diseases.

Purpose of the Study:

  • To investigate small molecules that can enhance the proteostasis network (PN) capacity.
  • To assess the potential of activating cellular stress responses and clearance mechanisms as a therapeutic strategy.
  • To protect cellular proteostasis against proteotoxicity and prevent damage in protein conformational diseases.

Main Methods:

  • Assessment of small molecules that activate the heat shock response.
  • Evaluation of compounds that stimulate the unfolded protein response.
  • Analysis of agents that enhance protein clearance mechanisms.

Main Results:

  • Small molecules can activate key cellular stress pathways, including the heat shock and unfolded protein responses.
  • Enhanced chaperone activity and clearance mechanisms increase the cell's capacity to manage proteotoxicity.
  • This strategy establishes a cytoprotective state against protein misfolding and aggregation.

Conclusions:

  • Enhancing the proteostasis network through small molecules is a viable therapeutic approach.
  • Activating cell stress pathways and chaperone activity offers protection against protein conformational diseases.
  • This strategy represents a promising avenue for preventing cellular damage in diseases associated with protein misfolding.

Related Concept Videos

Protein Denaturation01:28

Protein Denaturation

The function of proteins depends on their native three-dimensional structure, which is dictated by the amino acid sequence of the specific protein. Folding of the polypeptide chain takes place under specific conditions that energetically favor the folded conformation. In contrast, protein denaturation occurs spontaneously under unfavorable conditions that disrupt the integrity of the folded conformation. Thus, the chemical and physical environment of a protein, such as significant changes in pH...
Protein Folding01:22

Protein Folding

Overview
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding01:22

Protein Folding

Overview
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...